-+ 0.00%
-+ 0.00%
-+ 0.00%
Monivent Names Tobias Tullberg CEO, Effective January 4, 2027
Share
Listen to the news
Monivent Names Tobias Tullberg CEO, Effective January 4, 2027
  • Monivent appointed Tobias Tullberg CEO effective January 4, 2027, succeeding Maria Lindqvist.
  • Tullberg has led AprioMed as CEO since 2011 and has nearly 30 years of medical technology industry experience.
  • Lindqvist, a co-founder, will remain with the company in a new role focused on product development and clinical collaborations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monivent AB published the original content used to generate this news brief via Cision (Ref. ID: 202611181030BITN____UKPR__SV_20261118-BIT-1150-0) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending